Jeff Geschwind, MD is a key opinion leader in liver cancer treatment. His collaborative efforts with companies like HistoSonics are creating a new standard of care for patients seeking non-surgical alternatives for tumor ablation. https://medicine.yale.edu/news/yale-medicine-magazine/article/jeff-geschwind-md-to-chair-diagnostic-radiology/